Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 5/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13177047 | 0.75 | CHRM2 (0.42) | CHRM2CHRM1CHRM4CHRM3CYP2D6 | |
| SCHEMBL9073688 | 0.73 | — | — | |
| SCHEMBL19656394 | 0.72 | PTGS2 (0.36) | CHRM2CHRM1CHRM4CHRM3CYP2D6 | |
| Acetic Acid SCHEMBL27770131 | 0.72 | CHRM2 (0.40) | CHRM2CHRM1CHRM4CHRM3CYP2D6 | |
| SCHEMBL11161495 | 0.71 | TSHR (0.37) | ALOX15HSD11B1ABCB1 | |
| SCHEMBL318713 | 0.70 | CHRM2 (0.39) | CHRM2CHRM1CHRM4CHRM3CYP2D6 | |
| SCHEMBL15130720 | 0.70 | CHRM2 (0.39) | CHRM2CHRM1CHRM4CHRM3CYP2D6 | |
| SCHEMBL12165125 | 0.70 | CYP2D6 (0.40) | CHRM2CHRM1CHRM4CHRM3CYP2D6 | |
| SCHEMBL10266130 | 0.70 | CHRM2 (0.39) | CHRM2CHRM1CHRM4CHRM3CYP2D6 | |
| SCHEMBL318712 | 0.70 | CHRM2 (0.39) | CHRM2CHRM1CHRM4CHRM3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10307383-B2 | Cosmetic composition for preventing or ameliorating hypersensitive skin comprising cedrol or derivatives thereof, or pharmaceutically acceptable salts thereof | UNIVERSITY OF SEOUL INDUSTRY COOPERATION FOUNDATION (KR) | 2019-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10307383-B2 | Cosmetic composition for preventing or ameliorating hypersensitive skin comprising cedrol or derivatives thereof, or pharmaceutically acceptable salts thereof | IL17A, IL23R, HLA-DRB1 | CHRM2 4648/4885CHRM1 4664/4885CHRM4 4786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.